A clinical perspective

Nature

Volumn 502, Issue 7471, 2013, Pages 306-307

  Hudson, Thomas J ^a  

^a ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3A; NUCLEOTIDE; PROTEIN P53;

CANCER PROGNOSIS; CANCER REGISTRY; CLINICAL ASSESSMENT; CLINICAL FEATURE; GENE EXPRESSION; HUMAN; METASTASIS POTENTIAL; MUTATION; NEOPLASM; NOTE; PRIORITY JOURNAL;

EID: 84885767421     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/502306b     Document Type: Note

References (16)

1. www.nature.com/ng/focus/tcga/index.html
2. Kandoth, C. et al. Nature 502, 333-339 (2013).
3. Garraway, L. A. & Lander, E. S. Cell 153, 17-37 (2013).
4. Alexandrov, L. B. et al. Nature 500, 415-421 (2013).
5. Lawrence, M. S. et al. Nature 499, 214-218 (2013).
6. Ashworth, A., Lord, C. J. & Reis-Filho, J. S. Cell 145, 30-38 (2011).
7. Lord, C. J. & Ashworth, A. Nature 481, 287-294 (2012).
8. Stephens, P. J. et al. Cell 144, 27-40 (2011).
9. Nik-Zainal, S. et al. Cell 149, 979-993 (2012).
10. The Cancer Genome Atlas Research Network Nature Genet. 45, 1113-1120 (2013).
11. Glas, A. M. et al. BMC Genomics 7, 278 (2006).
12. Paik, S. et al. N. Engl. J. Med. 351, 2817-2826 (2004).
13. Dancey, J. E., Bedard, P. L., Onetto, N. & Hudson, T. J. Cell 148, 409-420 (2012).
14. Check Hayden, E. Nature 498, 16-17 (2013).
15. The International Cancer Genome Consortium Nature 464, 993-998 (2010).
16. The ENCODE Project Consortium Nature 489, 57-74 (2012).